At 36 months , the largest relative increase in SCAT was observed in the 0.03 mg MRrhTSH group ( 13.4 23.2 % ) , but this was not statistically different from the increases observed in the placebo or the 0.01 mg MRrhTSH group ( p = 0.15 ) .